Randomized phase III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer
Purpose Conventional radiotherapy (C-RT) treatment schedules for patients with prostate
cancer typically require 40 to 45 treatments that take place from> 8 to 9 weeks. Preclinical …
cancer typically require 40 to 45 treatments that take place from> 8 to 9 weeks. Preclinical …
[HTML][HTML] Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer
WR Lee, JJ Dignam, MB Amin, DW Bruner… - Journal of Clinical …, 2016 - escholarship.org
PurposeConventional radiotherapy (C-RT) treatment schedules for patients with prostate
cancer typically require 40 to 45 treatments that take place from> 8 to 9 weeks. Preclinical …
cancer typically require 40 to 45 treatments that take place from> 8 to 9 weeks. Preclinical …
Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer
WR Lee, JJ Dignam, MB Amin… - Journal of clinical …, 2016 - pubmed.ncbi.nlm.nih.gov
Purpose Conventional radiotherapy (C-RT) treatment schedules for patients with prostate
cancer typically require 40 to 45 treatments that take place from> 8 to 9 weeks. Preclinical …
cancer typically require 40 to 45 treatments that take place from> 8 to 9 weeks. Preclinical …
Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer.
WR Lee, JJ Dignam, MB Amin, DW Bruner… - Journal of Clinical …, 2016 - europepmc.org
Purpose Conventional radiotherapy (C-RT) treatment schedules for patients with prostate
cancer typically require 40 to 45 treatments that take place from> 8 to 9 weeks. Preclinical …
cancer typically require 40 to 45 treatments that take place from> 8 to 9 weeks. Preclinical …
Randomized phase III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer
WR Lee, JJ Dignam, MB Amin, DW Bruner… - Journal of Clinical …, 2016 - profiles.wustl.edu
Purpose: Conventional radiotherapy (C-RT) treatment schedules for patients with prostate
cancer typically require 40 to 45 treatments that take place from> 8 to 9 weeks. Preclinical …
cancer typically require 40 to 45 treatments that take place from> 8 to 9 weeks. Preclinical …
[HTML][HTML] Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer
WR Lee, JJ Dignam, MB Amin, DW Bruner… - Journal of Clinical …, 2016 - ncbi.nlm.nih.gov
Purpose Conventional radiotherapy (C-RT) treatment schedules for patients with prostate
cancer typically require 40 to 45 treatments that take place from> 8 to 9 weeks. Preclinical …
cancer typically require 40 to 45 treatments that take place from> 8 to 9 weeks. Preclinical …
Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer
WR Lee, JJ Dignam, MB Amin, DW Bruner… - Journal of Clinical …, 2016 - cir.nii.ac.jp
< jats: sec>< jats: title> Purpose</jats: title>< jats: p> Conventional radiotherapy (C-RT)
treatment schedules for patients with prostate cancer typically require 40 to 45 treatments …
treatment schedules for patients with prostate cancer typically require 40 to 45 treatments …
Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer.
WR Lee, JJ Dignam, MB Amin, DW Bruner… - Journal of Clinical …, 2016 - europepmc.org
Purpose Conventional radiotherapy (C-RT) treatment schedules for patients with prostate
cancer typically require 40 to 45 treatments that take place from> 8 to 9 weeks. Preclinical …
cancer typically require 40 to 45 treatments that take place from> 8 to 9 weeks. Preclinical …